Christine Ring sold $432K of NRIX stock

Christine Ring, Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX), sold 16,715 shares of NRIX stock worth $432K, per an SEC Form 4 filed Nov 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 2, 2026, 2 days before it was made public.

NRIX has moved -40.5% since the trade date, from $25.70 to $15.30 (Nov 6, 2026 close).